A prospective study of 1,000 stage II-III CRC patients found that distinct perioperative immunocircadian recovery trajectories were associated with postoperative ctDNA-based minimal residual disease and long-term survival outcomes. (Surgery)
Immune Recovery After Surgery Linked to ctDNA Minimal Residual Disease
The CRC Digest